Co May Pasdar Shirazi, MD
Pediatrics · Sugar Land, TXNPI 1487947685
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 28 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Avanos Medical at 42.9% of the total. Reporting peaked in 2021 at $258 and has fallen 59.1% since, to $105 in 2025.
Across 28 payments — averaging $32.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Avanos Medical$393
- Verrica Pharmaceuticals Inc.$246
- Lilly USA, LLC$80
- Cranial Technologies, Inc$49
- Amgen$41
- Exact Sciences$40
- plus $67 from 4 others
What the payments were for
- Food & beverage$916100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Avanos Medical | 3 | $393 |
| Verrica Pharmaceuticals Inc. | 10 | $246 |
| Lilly USA, LLC | 4 | $80 |
| Cranial Technologies, Inc | 3 | $49 |
| Amgen | 2 | $41 |
| Exact Sciences | 2 | $40 |
| GSK | 1 | $18 |
| Merck | 1 | $18 |
| Phadia US Inc. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ON-Q* PUMP AND ACCESSORIES$393
- YCANTH$104
How this compares
$916 in reported general payments places this provider in the 80th percentile of 5,361 pediatrics providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Mirtazapine | 12 | $267 |
| Levothyroxine Sodium | 27 | $219 |
| Atorvastatin Calcium | 17 | $200 |
| Lisinopril | 14 | $159 |
| Rosuvastatin Calcium | 23 | $143 |
| Amlodipine Besylate | 24 | $100 |
| Zolpidem Tartrate | 14 | $51 |
| Pregabalin | 12 | $49 |
| Metformin Hcl ErMetformin Hcl | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Sugar Land
- Andrea NguyenSugar Land$7K
- Pedro PiedraHouston$729K
- Jason RiehsFrisco$216K
- Ivonne Sahagun-CarreonNew Braunfels$168K
- Angela ScheuerleDallas$118K
- Dianna BurnsSan Antonio$100K
- Jason TerkKeller$93K
- Vernon SuttonHouston$90K
- Laura ScalfanoPlano$74K
- Patricia AmersonSan Antonio$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.